Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic

Mult Scler Relat Disord. 2020 Sep:44:102244. doi: 10.1016/j.msard.2020.102244. Epub 2020 Jun 2.
No abstract available

Keywords: COVID-19; Clinical practice; Multiple sclerosis treatments; Protocol; SARS-CoV-2 pandemic.

Publication types

  • Letter

MeSH terms

  • COVID-19 / complications*
  • Clinical Protocols*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / drug therapy*
  • Patient Safety

Substances

  • Immunologic Factors